Diabetes and dementia are more linked than thought
People with diabetes face a higher risk of dementia. But the relationship runs both ways: the two conditions reinforce each other through shared mechanisms in the brain.
New review research identifies ten connections between the two conditions, including disruptions to the brain’s energy supply, increased inflammatory activity, and damage to the small blood vessels involved in memory processing. The researchers argue that the overlap is deeper than previously recognized.
Insulin resistance (the reduced sensitivity of cells to insulin) plays a central role. Brain cells depend on a stable glucose supply. When that is disrupted, neurons may function less effectively. Chronically elevated blood sugar also appears to cause direct damage to cerebrovascular structures, increasing the risk of vascular dementia.
Can diabetes drugs protect the brain?
One notable finding in the review: some widely used diabetes medications may lower dementia risk. The researchers point to evidence suggesting that certain glucose-regulating drugs can also reduce inflammatory processes in the brain. These are associations from observational studies, not proof of causation.
Still, this opens new avenues for prevention research. If the same molecular pathways driving diabetes also affect cognitive decline, early treatment of glucose problems could potentially delay the onset of dementia. The researchers describe this as promising, but note that randomized trials are still needed.
Two sides of the same coin
The research also highlights that dementia itself can affect metabolism. People with cognitive decline tend to eat differently, exercise less, and can enter a downward spiral more quickly. Causal arrows run in both directions. That makes it harder to establish which condition drives the other, but it increases the clinical urgency of treating both together.
From a longevity perspective, this is relevant because insulin resistance and chronic low-grade inflammation (inflammaging) are two of the most studied aging mechanisms. Their overlap with dementia risk strengthens the hypothesis that metabolic health in midlife partially determines cognitive health in later years.